NCT00535951View on ClinicalTrials.gov

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

January 31, 2009

Conditions
Carcinoma, Non-Small-Cell LungMesothelioma
Interventions
DRUG

LBH589

Trial Locations (5)

30912

Medical College of Georgia, Augusta

60612

RUSH Medical Center, Chicago

72703

Highlands Oncology Group, Fayetteville

77030

MD Anderson Cancer Center, Houston

Unknown

Novartis Investigative Site, Ontario

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY